Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B2193481eef6a46c8a6fe3697a2b09aaa> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B2193481eef6a46c8a6fe3697a2b09aaa hasDbXref "Orphanet:1909" @default.
- B2193481eef6a46c8a6fe3697a2b09aaa type Axiom @default.
- B2193481eef6a46c8a6fe3697a2b09aaa annotatedProperty IAO_0000115 @default.
- B2193481eef6a46c8a6fe3697a2b09aaa annotatedSource MONDO_0016005 @default.
- B2193481eef6a46c8a6fe3697a2b09aaa annotatedTarget "Indomethacin embryofetopathy refers to the manifestations that may be observed in a fetus or newborn when the mother has taken indomethacin, a potent prostaglandin inhibitor and tocolytic agent that can cross placenta, during pregnancy. Reported adverse fetal/neonatal effects include decreased renal function resulting in oligohydramnios, closure of the ductus arteriosus, and delayed cardiovascular adaptation at birth. These effects are usually transient and reversible. Indomethacin may also be a risk factor for cerebral injury (periventricular leukomalacia) and necrotizing enterocolitisin preterm infants." @default.